Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Neuroimmunology

Assessing the value of plasma exchange in neurology

Nature Reviews Neurology volume 7, pages 309–310 (2011)Cite this article

Subjects

The American Academy of Neurology has updated its 1996 assessment of the value of plasma exchange in neurology. The report confirms the efficacy of plasma exchange in inflammatory neuropathy and possibly acute CNS demyelinating disease, but not in pediatric autoimmune neuropsychiatric disorders. Its conclusions, however, are limited by inadequate evidence.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Pinching, A. J., Peters, D. K. & Newsom-Davis, J. Remission of myasthenia gravis following plasma-exchange. Lancet 2, 1373–1376 (1976).

    Article  CAS  Google Scholar 

  2. Cortese, I. et al. Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 76, 294–300 (2011).

    Article  CAS  Google Scholar 

  3. [No authors listed] Assessment of plasmapheresis. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 47, 840–843 (1996).

  4. Hahn, A. F. et al. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study. Brain 119, 1055–1066 (1996).

    Article  Google Scholar 

  5. Gajdos, P., Chevret, S. & Toyka, K. Plasma exchange for myasthenia gravis. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD002275. doi:10.1002/14651858.CD002275 (2002).

  6. Gajdos, P., Chevret, S. & Toyka, K. Intravenous immunoglobulin for myasthenia gravis. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD002277. doi:10.1002/14651858.CD002277.pub3 (2008).

  7. Mandawat, A., Kaminski, H. J., Cutter, G., Katirji, B. & Alshekhlee, A. Comparative analysis of therapeutic options used for myasthenia gravis. Ann. Neurol. 68, 797–805 (2010).

    Article  Google Scholar 

  8. Weiner, H. L. et al. Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis. Neurology 39, 1143–1149 (1989).

    Article  CAS  Google Scholar 

  9. Lehmann, H. C. & Hartung, H. P. Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies. J. Neuroimmunol. 231, 61–69 (2010).

    Article  Google Scholar 

  10. Guyatt, G. H. et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336, 924–926 (2008).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cochrane Neuromuscular Disease Centre, MRC Centre for Neuromuscular Disease, PO Box 114, National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK

    Richard Hughes

  2. Department of Neurology, Heinrich-Heine-University Düsseldorf, Moorenstrasse 5, Düsseldorf, D-40225, Germany

    Hans-Peter Hartung

Authors
  1. Richard Hughes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans-Peter Hartung
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard Hughes.

Ethics declarations

Competing interests

R. Hughes is a consultant for Baxter, LFB, Talecris and Octapharma.

H.-P. Hartung is a consultant and speaker for, and receives grant/research support from, Biogen Idec, Bayer Schering, Novartis, Merck Sorono and Teva.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hughes, R., Hartung, HP. Assessing the value of plasma exchange in neurology. Nat Rev Neurol 7, 309–310 (2011). https://doi.org/10.1038/nrneurol.2011.59

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2011.59

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing